Skip to main content
Erschienen in: Acta Neurochirurgica 4/2014

01.04.2014 | Clinical Article - Neurosurgical Techniques

Fluorescence-guided surgery in high grade gliomas using an exoscope system

verfasst von: José Piquer Belloch, Vicente Rovira, Jose L. Llácer, Pedro A. Riesgo, Antonio Cremades

Erschienen in: Acta Neurochirurgica | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

Fluorescence-guided microsurgical resections of high-grade gliomas using 5-aminolevulinic acid (5-ALA) is superior to conventional microsurgery. An optical device, usually a modified microscope, is needed for these procedures. However, an exoscope may be implemented for fluorescence techniques. We present the use of an exoscope to perform tumor resection guided by 5-ALA fluorescence in 21 consecutive patients with high-grade glioma and two neuronavigation-guided biopsies.

Methods

Twenty-three patients underwent operations. Tumor volume and localization were quantified with pre- and postoperative volumetric MRI in non-biopsy cases.

Results

In non-biopsy cases, the age range was 20 to 79 years, with a median of 56 (interquartile range = 45-66). Histological analysis indicated that 14 had glioblastoma multiforme, 2 grade-III oligodendrogliomas and 1 anaplastic astrocytoma, 3 metastases and 1 low-grade astrocytoma. Total resection was achieved in 15 cases; subtotal resection was performed in 5 patients. The result was partial resection in one case. There was no perioperative mortality. The median fluorescence intensity, on a scale of 1–5, was 4.5 in the GBM group (IQR = 4-5), 3 (IQR = 2.5-3.5) in anaplastic glioma, and 2.5 (IQR = 2.25-2.75) for oligodendrogliomas. Of the three metastases, one showed fluorescence level 4. As for the two biopsy cases, one was anaplastic astrocytoma and one glioblastoma multiforme. The samples obtained were fluorescent in both cases.

Conclusions

An exoscope can be also used for fluorescence-guided surgery with 5-aminolevulinic acid (5-ALA) and neuronavigation-guided biopsy. With an important advantage of low cost, this allows the surgeon to perform collaborative surgeries and adds agility to the procedure.
Literatur
1.
Zurück zum Zitat Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109 Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109
2.
Zurück zum Zitat Pichlmeier U, Bink A, Schackert G, Stummer W (2008) Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol 10:1025–1034 Pichlmeier U, Bink A, Schackert G, Stummer W (2008) Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol 10:1025–1034
3.
Zurück zum Zitat Sanai N, Berger MS (2012) Recent surgical management of gliomas. Adv Exp Med Biol 746:12–25 Sanai N, Berger MS (2012) Recent surgical management of gliomas. Adv Exp Med Biol 746:12–25
4.
Zurück zum Zitat Stummer W, Reulen HJ, Meinel T, Pichlmeier U, Schumacher W, Tonn JC, Rohde V, Oppel F, Turowski B, Woiciechowsky C, Franz K, Pietsch T (2008) Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 62:564–576, discussion 564–576 Stummer W, Reulen HJ, Meinel T, Pichlmeier U, Schumacher W, Tonn JC, Rohde V, Oppel F, Turowski B, Woiciechowsky C, Franz K, Pietsch T (2008) Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 62:564–576, discussion 564–576
5.
Zurück zum Zitat Philip-Ephraim EE, Eyong KI, Williams UE, Ephraim RP (2012) The role of radiotherapy and chemotherapy in the treatment of primary adult high grade gliomas: assessment of patients for these treatment approaches and the common immediate side effects. ISRN Oncol 2012:902178 Philip-Ephraim EE, Eyong KI, Williams UE, Ephraim RP (2012) The role of radiotherapy and chemotherapy in the treatment of primary adult high grade gliomas: assessment of patients for these treatment approaches and the common immediate side effects. ISRN Oncol 2012:902178
6.
Zurück zum Zitat Yamaguchi S, Kobayashi H, Terasaka S, Ishii N, Ikeda J, Kanno H, Nishihara H, Tanaka S, Houkin K (2012) The impact of extent of resection and histological subtype on the outcome of adult patients with high-grade gliomas. Jpn J Clin Oncol 42:270–277 Yamaguchi S, Kobayashi H, Terasaka S, Ishii N, Ikeda J, Kanno H, Nishihara H, Tanaka S, Houkin K (2012) The impact of extent of resection and histological subtype on the outcome of adult patients with high-grade gliomas. Jpn J Clin Oncol 42:270–277
7.
Zurück zum Zitat Wang Y, Jiang T (2013) Understanding high grade glioma: molecular mechanism, therapy and comprehensive management. Cancer letters Wang Y, Jiang T (2013) Understanding high grade glioma: molecular mechanism, therapy and comprehensive management. Cancer letters
8.
Zurück zum Zitat Diez Valle R, Tejada Solis S, Idoate Gastearena MA, Garcia de Eulate R, Dominguez Echavarri P, Aristu Mendiroz J (2011) Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience. J Neurooncol 102:105--113 Diez Valle R, Tejada Solis S, Idoate Gastearena MA, Garcia de Eulate R, Dominguez Echavarri P, Aristu Mendiroz J (2011) Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience. J Neurooncol 102:105--113
9.
Zurück zum Zitat Panciani PP, Fontanella M, Garbossa D, Agnoletti A, Ducati A, Lanotte M (2012) 5-aminolevulinic acid and neuronavigation in high-grade glioma surgery: results of a combined approach. Neurocirugia (Astur) 23:23--28 Panciani PP, Fontanella M, Garbossa D, Agnoletti A, Ducati A, Lanotte M (2012) 5-aminolevulinic acid and neuronavigation in high-grade glioma surgery: results of a combined approach. Neurocirugia (Astur) 23:23--28
10.
Zurück zum Zitat Roberts DW, Valdes PA, Harris BT, Hartov A, Fan X, Ji S, Pogue BW, Leblond F, Tosteson TD, Wilson BC, Paulsen KD (2012) Adjuncts for maximizing resection: 5-aminolevuinic acid. Clin Neurosurg 59:75--78 Roberts DW, Valdes PA, Harris BT, Hartov A, Fan X, Ji S, Pogue BW, Leblond F, Tosteson TD, Wilson BC, Paulsen KD (2012) Adjuncts for maximizing resection: 5-aminolevuinic acid. Clin Neurosurg 59:75--78
11.
Zurück zum Zitat Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen H-J (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392--401 Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen H-J (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392--401
12.
Zurück zum Zitat von Campe G, Moschopulos M, Hefti M (2012) 5-Aminolevulinic acid-induced protoporphyrin IX fluorescence as immediate intraoperative indicator to improve the safety of malignant or high-grade brain tumor diagnosis in frameless stereotactic biopsies. Acta Neurochir (Wien) 154:585–588, discussion 588 von Campe G, Moschopulos M, Hefti M (2012) 5-Aminolevulinic acid-induced protoporphyrin IX fluorescence as immediate intraoperative indicator to improve the safety of malignant or high-grade brain tumor diagnosis in frameless stereotactic biopsies. Acta Neurochir (Wien) 154:585–588, discussion 588
13.
Zurück zum Zitat Bernal-Garcia LM, Cabezudo-Artero JM, Ortega-Martinez M, Fernandez-Portales I, Gimenez-Pando J, Ugarriza-Echebarrieta LF, Mata-Gomez J, Molina-Orozco M, Malca-Balcazar JF (2010) Fluorescence-guided resection with 5-aminolevulinic acid of an intramedullary tumor. Neurocirugia (Astur) 21:312–316 Bernal-Garcia LM, Cabezudo-Artero JM, Ortega-Martinez M, Fernandez-Portales I, Gimenez-Pando J, Ugarriza-Echebarrieta LF, Mata-Gomez J, Molina-Orozco M, Malca-Balcazar JF (2010) Fluorescence-guided resection with 5-aminolevulinic acid of an intramedullary tumor. Neurocirugia (Astur) 21:312–316
14.
Zurück zum Zitat Panciani PP, Fontanella M, Schatlo B, Garbossa D, Agnoletti A, Ducati A, Lanotte M (2012) Fluorescence and image guided resection in high grade glioma. Clin Neurol Neurosurg 114:37–41 Panciani PP, Fontanella M, Schatlo B, Garbossa D, Agnoletti A, Ducati A, Lanotte M (2012) Fluorescence and image guided resection in high grade glioma. Clin Neurol Neurosurg 114:37–41
15.
Zurück zum Zitat Potapov AA, Usachev DJ, Loshakov VA, Cherekaev VA, Kornienko VN, Pronin IN, Kobiakov GL, Kalinin PL, Gavrilov AG, Stummer W, Golbin DA, Zelenkov PV (2008) First experience in 5-ALA fluorescence-guided and endoscopically assisted microsurgery of brain tumors. Med Laser Appl 23:202–208 Potapov AA, Usachev DJ, Loshakov VA, Cherekaev VA, Kornienko VN, Pronin IN, Kobiakov GL, Kalinin PL, Gavrilov AG, Stummer W, Golbin DA, Zelenkov PV (2008) First experience in 5-ALA fluorescence-guided and endoscopically assisted microsurgery of brain tumors. Med Laser Appl 23:202–208
16.
Zurück zum Zitat Gildenberg PL, Ledoux R, Cosman E, Labuz J (1994) The exoscope--a frame-based video/graphics system for intraoperative guidance of surgical resection. Stereotac Funct Neurosurg 63:23–25 Gildenberg PL, Ledoux R, Cosman E, Labuz J (1994) The exoscope--a frame-based video/graphics system for intraoperative guidance of surgical resection. Stereotac Funct Neurosurg 63:23–25
17.
Zurück zum Zitat Mamelak AN, Danielpour M, Black KL, Hagike M, Berci G (2008) A high-definition exoscope system for neurosurgery and other microsurgical disciplines: preliminary report. Surg Innov 15:38–46 Mamelak AN, Danielpour M, Black KL, Hagike M, Berci G (2008) A high-definition exoscope system for neurosurgery and other microsurgical disciplines: preliminary report. Surg Innov 15:38–46
18.
Zurück zum Zitat Mamelak AN, Nobuto T, Berci G (2010) Initial clinical experience with a high-definition exoscope system for microneurosurgery. Neurosurg 67:476–483 Mamelak AN, Nobuto T, Berci G (2010) Initial clinical experience with a high-definition exoscope system for microneurosurgery. Neurosurg 67:476–483
19.
Zurück zum Zitat Eljamel MS (2008) Fluorescence image-guided surgery of brain tumors: explained step-by-step. Photodiagnosis and Photodynamic Therapy 5:260–263 Eljamel MS (2008) Fluorescence image-guided surgery of brain tumors: explained step-by-step. Photodiagnosis and Photodynamic Therapy 5:260–263
20.
Zurück zum Zitat Widhalm G, Minchev G, Woehrer A, Preusser M, Kiesel B, Furtner J, Mert A, Di Ieva A, Tomanek B, Prayer D, Marosi C, Hainfellner JA, Knosp E, Wolfsberger S (2012) Strong 5-aminolevulinic acid-induced fluorescence is a novel intraoperative marker for representative tissue samples in stereotactic brain tumor biopsies. Neurosurg Rev 35:381–391, discussion 391 Widhalm G, Minchev G, Woehrer A, Preusser M, Kiesel B, Furtner J, Mert A, Di Ieva A, Tomanek B, Prayer D, Marosi C, Hainfellner JA, Knosp E, Wolfsberger S (2012) Strong 5-aminolevulinic acid-induced fluorescence is a novel intraoperative marker for representative tissue samples in stereotactic brain tumor biopsies. Neurosurg Rev 35:381–391, discussion 391
21.
Zurück zum Zitat Shinoda J, Sakai N, Murase S, Yano H, Matsuhisa T, Funakoshi T (2001) Selection of eligible patients with supratentorial glioblastoma multiforme for gross total resection. J Neurooncol 52:161–171 Shinoda J, Sakai N, Murase S, Yano H, Matsuhisa T, Funakoshi T (2001) Selection of eligible patients with supratentorial glioblastoma multiforme for gross total resection. J Neurooncol 52:161–171
22.
Zurück zum Zitat Colditz MJ, Jeffree RL (2012) Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 1: Clinical, radiological and pathological studies. J Clin Neurosci 19:1471–1474 Colditz MJ, Jeffree RL (2012) Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 1: Clinical, radiological and pathological studies. J Clin Neurosci 19:1471–1474
23.
Zurück zum Zitat Cortnum S, Laursen RJ (2012) Fluorescence-guided resection of gliomas. Dan Med J 59:A4460 Cortnum S, Laursen RJ (2012) Fluorescence-guided resection of gliomas. Dan Med J 59:A4460
24.
Zurück zum Zitat Nabavi A, Thurm H, Zountsas B, Pietsch T, Lanfermann H, Pichlmeier U, Mehdorn M (2009) Five-aminolevulinic acid for fluorescence-guided resection of recurrent malignant gliomas: a phase ii study. Neurosurg 65:1070–1076, discussion 1076–1077 Nabavi A, Thurm H, Zountsas B, Pietsch T, Lanfermann H, Pichlmeier U, Mehdorn M (2009) Five-aminolevulinic acid for fluorescence-guided resection of recurrent malignant gliomas: a phase ii study. Neurosurg 65:1070–1076, discussion 1076–1077
25.
Zurück zum Zitat Roessler K, Becherer A, Donat M, Cejna M, Zachenhofer I (2012) Intraoperative tissue fluorescence using 5-aminolevolinic acid (5-ALA) is more sensitive than contrast MRI or amino acid positron emission tomography ((18)F-FET PET) in glioblastoma surgery. Neurol Res 34:314–317 Roessler K, Becherer A, Donat M, Cejna M, Zachenhofer I (2012) Intraoperative tissue fluorescence using 5-aminolevolinic acid (5-ALA) is more sensitive than contrast MRI or amino acid positron emission tomography ((18)F-FET PET) in glioblastoma surgery. Neurol Res 34:314–317
26.
Zurück zum Zitat Tykocki T, Michalik R, Bonicki W, Nauman P (2012) Fluorescence-guided resection of primary and recurrent malignant gliomas with 5-aminolevulinic acid. Preliminary results. Neurologia i neurochirurgia polska 46:47–51 Tykocki T, Michalik R, Bonicki W, Nauman P (2012) Fluorescence-guided resection of primary and recurrent malignant gliomas with 5-aminolevulinic acid. Preliminary results. Neurologia i neurochirurgia polska 46:47–51
27.
Zurück zum Zitat Carlucci C, Fasanella L, Ricci Maccarini A (2012) Exolaryngoscopy: a new technique for laryngeal surgery. Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 32:326–328 Carlucci C, Fasanella L, Ricci Maccarini A (2012) Exolaryngoscopy: a new technique for laryngeal surgery. Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 32:326–328
28.
Zurück zum Zitat Shirzadi A, Mukherjee D, Drazin DG, Paff M, Perri B, Mamelak AN, Siddique K (2012) Use of the video telescope operating monitor (VITOM) as an alternative to the operating microscope in spine surgery. Spine 37:E1517–1523 Shirzadi A, Mukherjee D, Drazin DG, Paff M, Perri B, Mamelak AN, Siddique K (2012) Use of the video telescope operating monitor (VITOM) as an alternative to the operating microscope in spine surgery. Spine 37:E1517–1523
29.
Zurück zum Zitat Wiwanitkit V (2012) VITOM in digital high-definition video exocolposcopy. Journal of lower genital tract disease 16:480, author reply 480–481 Wiwanitkit V (2012) VITOM in digital high-definition video exocolposcopy. Journal of lower genital tract disease 16:480, author reply 480–481
30.
Zurück zum Zitat Rapp M, Kamp M, Steiger HJ, Sabel M (2013) Endoscopic-assisted visualization of 5-Aminolevulinic acid-induced fluorescence in malignant glioma surgery: a technical note. World Neurosurg. doi:10.1016/j.wneu.2013.07.002 Rapp M, Kamp M, Steiger HJ, Sabel M (2013) Endoscopic-assisted visualization of 5-Aminolevulinic acid-induced fluorescence in malignant glioma surgery: a technical note. World Neurosurg. doi:10.​1016/​j.​wneu.​2013.​07.​002
Metadaten
Titel
Fluorescence-guided surgery in high grade gliomas using an exoscope system
verfasst von
José Piquer Belloch
Vicente Rovira
Jose L. Llácer
Pedro A. Riesgo
Antonio Cremades
Publikationsdatum
01.04.2014
Verlag
Springer Vienna
Erschienen in
Acta Neurochirurgica / Ausgabe 4/2014
Print ISSN: 0001-6268
Elektronische ISSN: 0942-0940
DOI
https://doi.org/10.1007/s00701-013-1976-6

Weitere Artikel der Ausgabe 4/2014

Acta Neurochirurgica 4/2014 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.